Carna Biosciences, Inc. (4572.T)
JPY 282.0
(0.0%)
JPY 282.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 140.14 Million JPY | 18.23% |
| 2022 | 118.53 Million JPY | 7.28% |
| 2021 | 110.48 Million JPY | 5.71% |
| 2020 | 104.52 Million JPY | 5.14% |
| 2019 | 99.41 Million JPY | -10.26% |
| 2018 | 110.78 Million JPY | -6.09% |
| 2017 | 117.96 Million JPY | -3.22% |
| 2016 | 121.89 Million JPY | -2.73% |
| 2015 | 125.31 Million JPY | 5.13% |
| 2014 | 119.2 Million JPY | 0.48% |
| 2013 | 118.62 Million JPY | 2.88% |
| 2012 | 115.3 Million JPY | 9.57% |
| 2011 | 105.23 Million JPY | -12.31% |
| 2010 | 119.99 Million JPY | 16.29% |
| 2009 | 103.19 Million JPY | 49.67% |
| 2008 | 68.94 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 147.47 Million JPY | 4.13% |
| 2024 Q1 | 141.62 Million JPY | 1.06% |
| 2023 Q4 | 140.14 Million JPY | 0.43% |
| 2023 Q2 | 139.91 Million JPY | 2.25% |
| 2023 FY | 140.14 Million JPY | 18.23% |
| 2023 Q3 | 139.54 Million JPY | -0.27% |
| 2023 Q1 | 136.83 Million JPY | 15.45% |
| 2022 Q3 | 116.67 Million JPY | 3.08% |
| 2022 Q2 | 113.18 Million JPY | 0.65% |
| 2022 Q1 | 112.45 Million JPY | 1.78% |
| 2022 FY | 118.53 Million JPY | 7.28% |
| 2022 Q4 | 118.53 Million JPY | 1.6% |
| 2021 Q3 | 109.82 Million JPY | -0.7% |
| 2021 Q2 | 110.6 Million JPY | -1.43% |
| 2021 Q1 | 112.2 Million JPY | 7.35% |
| 2021 Q4 | 110.48 Million JPY | 0.6% |
| 2021 FY | 110.48 Million JPY | 5.71% |
| 2020 Q2 | 91.81 Million JPY | 2.98% |
| 2020 Q1 | 89.15 Million JPY | -10.32% |
| 2020 FY | 104.52 Million JPY | 5.14% |
| 2020 Q4 | 104.52 Million JPY | 5.61% |
| 2020 Q3 | 98.97 Million JPY | 7.8% |
| 2019 FY | 99.41 Million JPY | -10.26% |
| 2019 Q1 | 105.46 Million JPY | -4.8% |
| 2019 Q2 | 103.7 Million JPY | -1.68% |
| 2019 Q3 | 104.48 Million JPY | 0.75% |
| 2019 Q4 | 99.41 Million JPY | -4.85% |
| 2018 Q3 | 140.29 Million JPY | -3.7% |
| 2018 Q4 | 110.78 Million JPY | -21.04% |
| 2018 Q2 | 145.69 Million JPY | -2.06% |
| 2018 FY | 110.78 Million JPY | -6.09% |
| 2018 Q1 | 148.75 Million JPY | 26.1% |
| 2017 Q3 | 118.23 Million JPY | 2.83% |
| 2017 FY | 117.96 Million JPY | -3.22% |
| 2017 Q4 | 117.96 Million JPY | -0.23% |
| 2017 Q2 | 114.98 Million JPY | -4.85% |
| 2017 Q1 | 120.84 Million JPY | -0.86% |
| 2016 Q1 | 113.92 Million JPY | -9.09% |
| 2016 FY | 121.89 Million JPY | -2.73% |
| 2016 Q4 | 121.89 Million JPY | -1.69% |
| 2016 Q3 | 123.98 Million JPY | 15.01% |
| 2016 Q2 | 107.8 Million JPY | -5.37% |
| 2015 Q2 | 119.6 Million JPY | -3.36% |
| 2015 Q1 | 123.76 Million JPY | 3.83% |
| 2015 FY | 125.31 Million JPY | 5.13% |
| 2015 Q4 | 125.31 Million JPY | 3.29% |
| 2015 Q3 | 121.33 Million JPY | 1.44% |
| 2014 FY | 119.2 Million JPY | 0.48% |
| 2014 Q4 | 119.2 Million JPY | -2.53% |
| 2014 Q3 | 122.29 Million JPY | -1.2% |
| 2014 Q2 | 123.77 Million JPY | -4.0% |
| 2014 Q1 | 128.94 Million JPY | 8.7% |
| 2013 FY | 118.62 Million JPY | 2.88% |
| 2013 Q1 | 120.1 Million JPY | 4.17% |
| 2013 Q2 | 133.58 Million JPY | 11.22% |
| 2013 Q3 | 126.24 Million JPY | -5.5% |
| 2013 Q4 | 118.62 Million JPY | -6.04% |
| 2012 FY | 115.3 Million JPY | 9.57% |
| 2012 Q2 | 111.22 Million JPY | 7.56% |
| 2012 Q3 | 110.84 Million JPY | -0.34% |
| 2012 Q4 | 115.3 Million JPY | 4.02% |
| 2012 Q1 | 103.4 Million JPY | -1.74% |
| 2011 FY | 105.23 Million JPY | -12.31% |
| 2011 Q4 | 105.23 Million JPY | -7.47% |
| 2011 Q1 | 118.33 Million JPY | -1.39% |
| 2011 Q3 | 113.73 Million JPY | -1.62% |
| 2011 Q2 | 115.6 Million JPY | -2.3% |
| 2010 Q1 | 106.78 Million JPY | 3.48% |
| 2010 Q2 | 121.53 Million JPY | 13.82% |
| 2010 Q4 | 119.99 Million JPY | -4.36% |
| 2010 FY | 119.99 Million JPY | 16.29% |
| 2010 Q3 | 125.46 Million JPY | 3.23% |
| 2009 Q4 | 103.19 Million JPY | 8.02% |
| 2009 Q3 | 95.53 Million JPY | 0.01% |
| 2009 Q2 | 95.51 Million JPY | 15.33% |
| 2009 Q1 | 82.82 Million JPY | 0.0% |
| 2009 FY | 103.19 Million JPY | 49.67% |
| 2008 FY | 68.94 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 79.482% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -681.639% |
| GNI Group Ltd. | 2.33 Billion JPY | 93.987% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 93.709% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -107.673% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 87.497% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -35.357% |
| AnGes, Inc. | 1.61 Billion JPY | 91.327% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -89.381% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 95.173% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 56.466% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -76063.043% |
| CanBas Co., Ltd. | 728 Thousand JPY | -19150.0% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -59.498% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 5.272% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -118.603% |
| Kidswell Bio Corporation | 875.65 Million JPY | 83.996% |
| PeptiDream Inc. | 2.4 Billion JPY | 94.171% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -2523.362% |
| Ribomic Inc. | 2.27 Million JPY | -6062.709% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -14013999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -289.278% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -383.241% |
| CellSource Co., Ltd. | 305.92 Million JPY | 54.191% |
| FunPep Company Limited | 25.54 Million JPY | -448.686% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 61.506% |
| Stella Pharma Corporation | 1.11 Billion JPY | 87.446% |
| TMS Co., Ltd. | 50.02 Million JPY | -180.14% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -570.494% |
| Cuorips Inc. | 1.04 Million JPY | -13336.242% |
| K Pharma,Inc. | 10.79 Million JPY | -1198.314% |
| Takara Bio Inc. | 11.85 Billion JPY | 98.817% |
| ReproCELL Incorporated | 248.14 Million JPY | 43.524% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 68.898% |
| StemCell Institute Inc. | 42.26 Million JPY | -231.598% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 38.687% |
| CellSeed Inc. | 46.19 Million JPY | -203.392% |